Screener
AnaptysBio, Inc. ANAB EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from AnaptysBio, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
FAQ
- What is AnaptysBio, Inc.'s EBITDA margin?
- AnaptysBio, Inc. (ANAB) reported EBITDA margin of 17.8% in Q1 2026.
- How has AnaptysBio, Inc.'s EBITDA margin changed year-over-year?
- AnaptysBio, Inc.'s EBITDA margin increased by 120.0% year-over-year, from -89.1% to 17.8%.
- What is the long-term trend for AnaptysBio, Inc.'s EBITDA margin?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s EBITDA margin has grown at a -30.6% compound annual growth rate (CAGR), from -89% to 20.7%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about AnaptysBio, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude